Table 1.
Demographic and Baseline Disease Characteristics
| No Dyskinesia | Non-troublesome Dyskinesia Only | Troublesome Dyskinesia | |
| (N = 183) | (N = 131) | (N = 79) | |
| Age (years) | 64.1 (9.81) | 63.7 (9.05) | 60.5 (8.65) |
| Sex, male | 119 (65.0) | 90 (68.7) | 45 (57.0) |
| Parkinson’s disease duration (years) | 6.06 (4.023) | 8.24 (4.641) | 9.23 (4.311) |
| UPDRS I + II + III | 34.6 (15.93) | 33.8 (14.54) | 33.9 (15.40) |
| Daily OFF time (hours) | 6.40 (2.328) | 5.70 (1.925) | 5.43 (1.707) |
| Daily ON-time with non-troublesome dyskinesia (hours) | 0.00 (0.00) | 2.81 (2.773) | 3.18 (1.953) |
| Daily ON-time with troublesome dyskinesia (hours) | 0.00 (0.00) | 0.00 (0.00) | 1.80 (1.432) |
| Daily ON-time without troublesome dyskinesia (hours) | 9.83 (2.251) | 10.82 (2.058) | 9.19 (2.691) |
| Daily levodopa dose (mg) | 756.4 (376.70) | 770.1 (333.80) | 830.1 (326.66) |
| Daily number of levodopa intakes | 4.7 (1.13) | 5.1 (1.39) | 5.7 (2.31) |
Data are Mean (SD) or n (%). UPDRS, Unified Parkinson’s Disease Rating Scale. UPDRS II and III are in the ON-state.